The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Rudnic Edward M since 2006.
The trader's CIK number is 1263483.
At the time of the last reporting, Rudnic Edward M was the President and CEO of Advancis Pharmaceutical Corp. (stock ticker symbol AVNC).
Also see all insider trading activities at Advancis Pharmaceutical Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | MBRK | 0 | $0 | 160,000 | $288,996 | 0 | $0 |
| 2006 | MBRK | 0 | $0 | 160,000 | $466,449 | 221,299 | $111,755 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-11-26 | MBRK | Sale | 11,400 | 1.10 | 12,597 |
| 2007-11-20 | MBRK | Sale | 5,000 | 1.15 | 5,729 |
| 2007-11-21 | MBRK | Sale | 4,300 | 1.09 | 4,687 |
| 2007-11-23 | MBRK | Sale | 2,400 | 1.04 | 2,508 |
| 2007-11-16 | MBRK | Sale | 1,300 | 1.18 | 1,534 |
| 2007-11-15 | MBRK | Sale | 5,400 | 1.21 | 6,534 |
| 2007-11-19 | MBRK | Sale | 10,200 | 1.18 | 12,036 |
| 2007-10-18 | MBRK | Sale | 12,600 | 1.43 | 18,018 |
| 2007-10-15 | MBRK | Sale | 7,700 | 1.59 | 12,281 |
| 2007-10-16 | MBRK | Sale | 9,000 | 1.54 | 13,905 |
| 2007-10-17 | MBRK | Sale | 10,700 | 1.49 | 15,943 |
| 2007-09-17 | MBRK | Sale | 13,100 | 2.23 | 29,147 |
| 2007-09-18 | MBRK | Sale | 26,900 | 2.24 | 60,336 |
| 2007-08-23 | MBRK | Sale | 11,000 | 2.36 | 25,938 |
| 2007-08-22 | MBRK | Sale | 16,000 | 2.37 | 37,904 |
| 2007-08-24 | MBRK | Sale | 13,000 | 2.30 | 29,899 |
| 2006-11-21 | AVNC | Sale | 10,000 | 4.07 | 40,679 |
| 2006-09-20 | AVNC | Sale | 40,000 | 5.61 | 224,360 |
| 2006-02-16 | AVNC | Option Ex | 221,299 | .51 | 111,755 |
| 2006-02-16 | AVNC | Sale | 110,000 | 1.83 | 201,410 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rudnic Edward M (President and CEO of Advancis Pharmaceutical Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.